HIV Cure Update: Who's More Successful - Gilead And GlaxoSmithKline?
Two of the pharmaceutical giants, Gilead Sciences and GlaxoSmithKline, are both set for a face off against each other after they have officially announced the launching of their versions of cure for HIV. It was recently revealed that the two biotechnology companies will be presenting their clinical results of their competing HIV drugs at an HIV conference in Seattle, Washington next week. The said presentations are bound to take place next week as revealed by authorities from both parties.
Gilead's Quest For HIV
According to reports revealed by Investopedia, Gilead's bictegravir, which was formerly named as GS-9883, is said to be the much-touted new-age integrates inhibitor. Gilead authorities have also added that their bictegravir has allegedly been approved by the U.S. Food And Drug Administration (FDA) in August 2013 to treating HIV infection. Experts from the said company claim that bictegravir has the ability to offer advantages of better drug effectiveness along with limited side effects.
GlaxoSmithKline's Version Of HIV Cure
Meanwhile, as per Specialty Pharmacy Times, GlaxoSmithKline or GSK's dolutegravir is bound to highlight the advantages of its new 2-drug combination treatment regimen for HIV, as compared with the conventional 3-drug cocktails. In one of his statements, chief executive of GSK, Andrew Witty has claimed that dolutegravir's Holy Grail was the fact that it has been proven to have a track record in preventing the virus from becoming drug resistant. Witty adds that dolutegravir has an extremely impressive resistance profile.
On the other hand, it was found that GlaxoSmithKline has already reported success in clinical trials conducted last December. While it was said that the results from Gilead's phase 2 trial comparing bictegravir with dolutegravir used as part of a drug-drug combination is allegedly set to be presented at the Conference on Retroviruses and Opportunistic Infections on February 13, 2017. Ultimately, a significant number of experts believe that the public will be the ones who will benefit the most since the end-target is to determine which of these promising drugs do have the ability to treat patients with HIV.
Elon Musk Is Working On A Consensual Telepathy; Latest Details Inside
Elon Musk has confirmed that Neuralink is real and that he is serious about the technology. The firm will soon develop a “neural lace” technology that would involve implanting tiny brain electrodes.
HIV, The Next Target Of Trump Administration
As continuous efforts to eradicate HIV are taking place, why does the Trump administration wanted to halt the treatment that has been started by the previous government? What’s the truth behind claims that if the current US President would push this through, it will kill thousands? Find out what authorities have to say
How Do We Reduce HIV Risk? Here Are Experts' Tips
With the continuous efforts to eradicate one of the world's long dreaded disease, can we really do certain precautionary measures to prevent the risk of HIV? What are the necessary steps to prevent transmission of the disease? Find out what experts have to say
HIV Vaccine Cures Five Patients For Seven Months
New AIDS vaccine developed in Spain have reportedly cured 5 patients, helping them remain virus-free for seven months after taking the treatment. In the study, the treatment allowed the patients to stop taking regular antiretroviral (ARV) drugs to suppress HIV symptoms.
Nanotechnology For HIV: New Technique Shows Promising Results In HIV Treatment
With continuous efforts to eradicate HIV being one of the world's long dreaded disease, how essential does nanotechnology's role can be? What's the truth behind claims that this new technique offers a new hope as it has induced positive results in HIV treatment? Could it be the answer to the disease? Find out what experts have to say
PrEP For HIV: Raising Awareness; Could It Be The Cure For The Disease?
Considering that HIV has been and is still currently is one of the world’s most dreaded diseases, how essential is the use of PrEP? Could it possibly hold the key for cure that a lot of people have been waiting for? What’s the truth behind claims these claims? Find out what health professionals have to say
MORE IN ITECHPOST
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.